Klein Lawrence Otto Insider Trades & Stock Holdings

Chief Executive Officer · Oruka Therapeutics, Inc. · Latest filing Oct 1, 2026

Klein Lawrence Otto, Chief Executive Officer at Oruka Therapeutics, Inc. has 2 Form 4 trades on file since Jun 15, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($2.21M), net -$2.21M. Latest filing: disposed of 25K shares of $ORKA on Oct 1, 2026 at $83.62.

Trades on file

2

Open-market bought

$0

Open-market sold

$2.21M

Net open-market

-$2.21M

Latest filing

Oct 1, 2026

All insider trades by Klein Lawrence Otto

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$ORKA	Sell (Open-market sale) 10b5-1	25K	$83.62	$2.09M			-7.4%			Chief Executive Officer		—
Jun 15, 2026	$ORKA	Sell (Open-market sale)	1.73K	$69.69	$120.49K			+24.0%	+25.8%		Chief Executive Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Klein Lawrence Otto traded

• $ORKA

Frequently asked questions

Has Klein Lawrence Otto been buying or selling stock?

Klein Lawrence Otto has 0 open-market purchases and 2 open-market sales on file, net -$2.21M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Klein Lawrence Otto's latest insider trade?

disposed of 25K shares of $ORKA on Oct 1, 2026 at $83.62.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.